XM does not provide services to residents of the United States of America.

US Senator Bernie Sanders bids to halt some weapons sales to Israel



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US Senator Bernie Sanders bids to halt some weapons sales to Israel</title></head><body>

By Patricia Zengerle

WASHINGTON, Sept 18 (Reuters) -U.S. Senator Bernie Sanders said on Wednesday he would file legislation seeking to block the sale of offensive U.S. weapons to Israel, citing the toll on civilians of Israel's campaign against Hamas.

Sanders, an independent who caucuses with Democrats, said he intended to file Joint Resolutions of Disapproval next week.

The U.S. Arms Export Control Act gives Congress the right to stop a major foreign weapons sale by passing a resolution of disapproval. Although no such resolution has both passed Congress and survived a presidential veto, the law requires the Senate to vote if a resolution is filed and they have at times led to angry debates embarrassing to past presidents.

"Providing more offensive weapons to continue this disastrous war would violate U.S. and international law," Sanders said in a statement.

President Joe Biden has faced calls from his fellow Democrats throughout Israel's campaign in Gaza to press Israeli Prime Minister Benjamin Netanyahu's government to ease the devastating humanitarian crisis in the Palestinian enclave.

In his announcement, Sanders noted that the Biden administration last month approved arms sales to Israel totaling more than $20 billion that included systems tied to tens of thousands of civilian deaths in Gaza. He said exporting such weapons would violate human rights provisions in the Foreign Assistance Act of 1961 and Arms Export Control Act.

The White House did not immediately respond to a request for comment on Sanders' announcement.

The war in the Gaza Strip began on Oct. 7, 2023, when Hamas gunmen stormed into Israeli communities, killing some 1,200 people and abducting about 250 hostages, according to Israeli tallies.

Since then, Israel's military has leveled swaths of Gaza, driving nearly all of its 2.3 million people from their homes, giving rise to deadly hunger and disease and killing more than 41,000 people, according to Palestinian health authorities.

The U.S., Israel's biggest ally and weapons supplier, has sent Israel more than 10,000 highly destructive 2,000-pound (900-kg) bombs and thousands of Hellfire missiles since the start of the Gaza war in October, U.S. officials told Reuters in June.



Reporting by Patricia Zengerle; editing by Jonathan Oatis

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.